Otsuka Pharmaceutical Development & Commercialization recalls
FDA enforcement reports naming Otsuka Pharmaceutical Development & Commercialization, Inc. as the recalling firm.
- Recall reports
- 2
- Class I (serious)
- 0
- Most recent report
- Oct 10, 2018
- Oct 10, 2018treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for extended…Drug · Otsuka Pharmaceutical Development & Commercialization, Inc.Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the ou…Class III
- Oct 10, 2018treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for extended r…Drug · Otsuka Pharmaceutical Development & Commercialization, Inc.Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the ou…Class III